Company Filing History:
Years Active: 1996-2012
Title: Lars Korsnes: Innovator in Nucleic Acid Isolation
Introduction
Lars Korsnes is a notable inventor based in Oslo, Norway. He has made significant contributions to the field of molecular biology, particularly in the area of nucleic acid isolation. With a total of 3 patents to his name, Korsnes has developed innovative methods that enhance the efficiency of nucleic acid extraction from biological samples.
Latest Patents
One of his latest patents focuses on a method for isolating nucleic acid from a blood sample. This method involves selectively isolating leucocytes by binding them to a solid support using a binding partner specific for leucocytes. Following this, the isolated leucocytes are lysed, and the nucleic acid released from these cells is bound to the solid support. Additionally, he has developed kits for isolating nucleic acid from various samples, further expanding the utility of his invention.
Another significant patent by Korsnes is a process for producing complementary DNA (cDNA). This process includes several steps, such as contacting a liquid containing mRNA with an insoluble support that has DNA probes attached. The mRNA hybridizes to these probes, allowing for the production of single-stranded cDNA. The use of magnetic particles in this process enhances the efficiency and specificity of the cDNA production.
Career Highlights
Throughout his career, Lars Korsnes has worked with prominent companies in the biotechnology sector, including Dynal AS and Invitrogen. His experience in these organizations has contributed to his expertise in molecular biology and patent development.
Collaborations
Korsnes has collaborated with several professionals in his field, including Erik Hornes and Jack Andreassen. These collaborations have likely enriched his research and innovation efforts.
Conclusion
Lars Korsnes is a distinguished inventor whose work in nucleic acid isolation has made a significant impact in the field of molecular biology. His innovative patents and collaborations reflect his commitment to advancing scientific research and technology.